Pro Pharma Talks

1. Goal:  Lower drug cost so that they are affordable to patients      a. US Rate of Inflation (2017-2019) = 2.14% to 1.8%      b. CPI = 2.0%      c. CPI (health care) = 2.8% (2019) 2. Drug Cost Transparency      a. Transparency = cost      b. CA SB17: WAC >= $40 with 16% inflation in prior year, or 32% inflation in last 2 years 3. How do they differ?  Are they effective?  Pros/Cons      a. White House Plan      b. Congressional Action      c. Congress – Democratic Plan 4. State Plans – What are they trying to do?  Pros/Cons      a. California      b. New York  5. Discount Programs      a. GoodRx      b. TimesRx      c. Misc. 6. PhRMA unregulated for innovation &